Tesamorelin 20mg

Description

Tesamorelin 20mg, presented as a distinct catalog variant

Purity Collective lists Tesamorelin 20mg as a separate quantity variant for qualified laboratory procurement. The page is intentionally limited to facts supported by the current catalog record, making it clear what is published and what still requires confirmation before an internal acceptance decision.

This 20mg listing must be evaluated independently from the Tesamorelin 10mg product. A shared compound name does not make the two quantities, inventory records, lots or supporting documents interchangeable.

Current product record

Documentation status

No product-specific UPLC/MS, identity, quantity, purity or endotoxin report is currently attached to the Tesamorelin 20mg listing. Purity Collective therefore does not present a lot number, numerical analytical result, test date or pass-style quality claim for this variant. For identity, FDA product-status boundaries and quantity-specific record review, read the Tesamorelin research and COA guide.

The documents published on the 10mg page describe that separate catalog record and must not be used as evidence for this 20mg listing. Before procurement, request the documents applicable to the offered inventory and match the compound, stated quantity, lot, dates, methods, specifications and results. The guide to reading a peptide COA explains how to review those fields when records become available.

Why the variants remain separate

Quantity-specific pages help laboratories avoid transferring details from one catalog record to another. The 10mg and 20mg listings have different stated quantities and must maintain their own product facts, inventory records and document trails. Keeping those boundaries visible is more useful than repeating broad claims across both pages.

Procurement record review

• Confirm that Tesamorelin and the stated 20mg quantity match the procurement request.
• Request the current SKU, supplied format and product-specific analytical documents.
• Do not use the Tesamorelin 10mg reports as evidence for this variant.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

Tesamorelin 20mg FAQs

What is listed on this Tesamorelin 20mg page?

The current catalog record identifies Tesamorelin with a stated quantity of 20mg. It does not currently publish a SKU or structured format attribute.

Are product-specific analytical documents available?

No product-specific analytical PDFs are currently attached to this listing. Request the records applicable to the offered 20mg inventory before making an internal acceptance decision.

Can the Tesamorelin 10mg reports be used for this variant?

No. The 10mg documents belong to a separate quantity-specific listing. They should not be treated as evidence for the identity, lot, quantity or analytical status of the 20mg inventory.

What should a laboratory confirm before procurement?

Confirm the compound, stated quantity, SKU, supplied format and current lot-specific documents. Then evaluate the report methods, dates, specifications and results under the laboratory’s own procedures.

Is Tesamorelin 20mg intended for human use?

No. This product is listed only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.